Back to Search
GREGORY BIGELOW, D.M.D.
D.M.D.
General Practice Dentistry
NPI: 1821080177Individual
Specialties, Licenses & Credentials
General Practice DentistryPrimary
Dentist — General Practice
Code: 1223G0001X
D5659(OR)
Research & Publications (20)
Repeated dosing with oral cocaine in humans: assessment of direct effects, withdrawal, and pharmacokinetics.
PMID 19653786·Exp Clin Psychopharmacol·2009
2-rct
Concurrent validation of the Clinical Opiate Withdrawal Scale (COWS) and single-item indices against the Clinical Institute Narcotic Assessment (CINA) opioid withdrawal instrument.
PMID 19647958·Drug Alcohol Depend·2009
4-observational
Opioid detoxification via single 7-day application of a buprenorphine transdermal patch: an open-label evaluation.
PMID 18327673·Psychopharmacology (Berl)·2008
8-other
Abstinence-contingent reinforcement and engagement in non-drug-related activities among illicit drug abusers.
PMID 19071979·Psychol Addict Behav·2008
4-observational
The health encounter as a treatable moment for homeless substance-using adults: the role of homelessness, health seeking behavior, readiness for behavior change and motivation for treatment.
PMID 18562126·Addict Behav·2008
8-other
Pharmacokinetics and pharmacodynamics of methadone enantiomers after coadministration with fosamprenavir-ritonavir in opioid-dependent subjects.
PMID 18576901·Pharmacotherapy·2008
3-trial
Evaluation of the mu and kappa opioid actions of butorphanol in humans through differential naltrexone blockade.
PMID 17909753·Psychopharmacology (Berl)·2008
2-rct
Modest opioid withdrawal suppression efficacy of oral tramadol in humans.
PMID 17605004·Psychopharmacology (Berl)·2007
4-observational
Factors identifying high-frequency and low-frequency health service utilization among substance-using adults.
PMID 17588489·J Subst Abuse Treat·2007
8-other
QT-interval effects of methadone, levomethadyl, and buprenorphine in a randomized trial.
PMID 18071169·Arch Intern Med·2007
4-observational
Contingency management in cocaine abusers: a dose-effect comparison of goods-based versus cash-based incentives.
PMID 17696680·Exp Clin Psychopharmacol·2007
3-trial
Evaluation of a transdermal buprenorphine formulation in opioid detoxification.
PMID 17854341·Addiction·2007
3-trial
The effect of integrated medical-substance abuse treatment during an acute illness on subsequent health services utilization.
PMID 18049353·Med Care·2007
8-other
Sublingual buprenorphine/naloxone precipitated withdrawal in subjects maintained on 100mg of daily methadone.
PMID 17517480·Drug Alcohol Depend·2007
2-rct
Comparing the physiological and subjective effects of self-administered vs yoked cocaine in humans.
PMID 16552557·Psychopharmacology (Berl)·2006
4-observational
Assessment of agonist and antagonist effects of tramadol in opioid-dependent humans.
PMID 16756415·Exp Clin Psychopharmacol·2006
8-other
Managing acutely ill substance-abusing patients in an integrated day hospital outpatient program: medical therapies, complications, and overall treatment outcomes.
PMID 16808738·J Gen Intern Med·2006
8-other
Physical health as a motivator for substance abuse treatment among medically ill adults: is it enough to keep them in treatment?
PMID 16919741·J Subst Abuse Treat·2006
8-other
HIV risk behaviors during pharmacologic treatment for opioid dependence: a comparison of levomethadyl acetate [corrected] buprenorphine, and methadone.
PMID 16919747·J Subst Abuse Treat·2006
2-rct
Effects associated with double-blind omission of buprenorphine/naloxone over a 98-h period.
PMID 17013637·Psychopharmacology (Berl)·2006
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 350 MERIDIAN WAY
GRANTS PASS, OR 97527 - Phone
- (541) 476-4199
Quick Facts
- NPI
- 1821080177
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile